{"id":"https://openalex.org/W7224969266","doi":"https://doi.org/10.5281/zenodo.23799154","title":"REGULATORY REQUIREMENTS FOR PAEDIATRIC ONCOLOGY DRUGS AS PER CDSCO IN INDIA COMPARISION WITH JAPAN","display_name":"REGULATORY REQUIREMENTS FOR PAEDIATRIC ONCOLOGY DRUGS AS PER CDSCO IN INDIA COMPARISION WITH JAPAN","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7224969266","doi":"https://doi.org/10.5281/zenodo.23799154"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23799154","doi":"https://doi.org/10.5281/zenodo.23799154","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23799154","pdf_url":null,"source":{"id":"https://openalex.org/S4210212542","display_name":"European Journal Pharmaceutical and Medical Research","issn_l":"2394-3211","issn":["2394-3211"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4383694718","host_organization_name":"World Journal of Pharmacy and Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4383694718"],"host_organization_lineage_names":["World Journal of Pharmacy and Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.5281/zenodo.23799154","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160204027","display_name":"Ashok Kumar P.*, Bhavana M. S., Chaitra S. H., Keerthana H. C., Nirupama T. S., Vathsala Vishwakarma S.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ashok Kumar P.*, Bhavana M. S., Chaitra S. H., Keerthana H. C., Nirupama T. S., Vathsala Vishwakarma S.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5160204027"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.8915843,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-regulation","display_name":"drug regulation","score":0.8999999761581421},{"id":"https://openalex.org/keywords/cdsco","display_name":"CDSCO","score":0.6669999957084656},{"id":"https://openalex.org/keywords/regulatory-framework","display_name":"regulatory framework","score":0.6349999904632568},{"id":"https://openalex.org/keywords/pediatric-drug-formulation","display_name":"pediatric formulations","score":0.7289999723434448},{"id":"https://openalex.org/keywords/age-appropriate-dosing","display_name":"age-appropriate dosing","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pediatric-clinical-trials","display_name":"pediatric clinical trials","score":0.847000002861023},{"id":"https://openalex.org/keywords/drug-labeling","display_name":"drug labeling","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pharmaceutical-innovation-incentives","display_name":"pharmaceutical innovation incentives","score":0.6809999942779541},{"id":"https://openalex.org/keywords/patient-access","display_name":"patient access","score":0.7940000295639038},{"id":"https://openalex.org/keywords/india","display_name":"India","score":0.47200000286102295},{"id":"https://openalex.org/keywords/japan","display_name":"Japan","score":0.972000002861023}],"concepts":[{"id":"https://openalex.org/C2775884135","wikidata":"https://www.wikidata.org/wiki/Q845436","display_name":"Mandate","level":2,"score":0.7389000058174133},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7315999865531921},{"id":"https://openalex.org/C29122968","wikidata":"https://www.wikidata.org/wiki/Q1414816","display_name":"Incentive","level":2,"score":0.49970000982284546},{"id":"https://openalex.org/C521751864","wikidata":"https://www.wikidata.org/wiki/Q1729207","display_name":"Christian ministry","level":2,"score":0.4749000072479248},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4611999988555908},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4390999972820282},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.39739999175071716},{"id":"https://openalex.org/C2777351106","wikidata":"https://www.wikidata.org/wiki/Q49371","display_name":"Legislation","level":2,"score":0.382099986076355},{"id":"https://openalex.org/C2909998350","wikidata":"https://www.wikidata.org/wiki/Q35456","display_name":"Essential drugs","level":4,"score":0.32899999618530273},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.3221000134944916},{"id":"https://openalex.org/C100243477","wikidata":"https://www.wikidata.org/wiki/Q12002092","display_name":"Welfare","level":2,"score":0.3167000114917755},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.31360000371932983},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.3125999867916107},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.30559998750686646},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.3012999892234802},{"id":"https://openalex.org/C2775924081","wikidata":"https://www.wikidata.org/wiki/Q55608371","display_name":"Control (management)","level":2,"score":0.29840001463890076},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.2962999939918518},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.28769999742507935},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.28630000352859497},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.27219998836517334},{"id":"https://openalex.org/C47344431","wikidata":"https://www.wikidata.org/wiki/Q1519812","display_name":"Health policy","level":3,"score":0.27000001072883606},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.2614000141620636},{"id":"https://openalex.org/C160050368","wikidata":"https://www.wikidata.org/wiki/Q132453","display_name":"Developed country","level":3,"score":0.2612999975681305},{"id":"https://openalex.org/C2776654903","wikidata":"https://www.wikidata.org/wiki/Q2601463","display_name":"SAFER","level":2,"score":0.2556000053882599},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.25130000710487366}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23799154","doi":"https://doi.org/10.5281/zenodo.23799154","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23799154","pdf_url":null,"source":{"id":"https://openalex.org/S4210212542","display_name":"European Journal Pharmaceutical and Medical Research","issn_l":"2394-3211","issn":["2394-3211"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4383694718","host_organization_name":"World Journal of Pharmacy and Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4383694718"],"host_organization_lineage_names":["World Journal of Pharmacy and Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23799155","doi":"https://doi.org/10.5281/zenodo.23799155","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23799155","pdf_url":null,"source":{"id":"https://openalex.org/S4210212542","display_name":"European Journal Pharmaceutical and Medical Research","issn_l":"2394-3211","issn":["2394-3211"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4383694718","host_organization_name":"World Journal of Pharmacy and Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4383694718"],"host_organization_lineage_names":["World Journal of Pharmacy and Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23799154","doi":"https://doi.org/10.5281/zenodo.23799154","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23799154","pdf_url":null,"source":{"id":"https://openalex.org/S4210212542","display_name":"European Journal Pharmaceutical and Medical Research","issn_l":"2394-3211","issn":["2394-3211"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4383694718","host_organization_name":"World Journal of Pharmacy and Pharmaceutical Sciences","host_organization_lineage":["https://openalex.org/P4383694718"],"host_organization_lineage_names":["World Journal of Pharmacy and Pharmaceutical Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7105528922","https://openalex.org/W4404084387","https://openalex.org/W7216533694","https://openalex.org/W7104266420","https://openalex.org/W7171784577","https://openalex.org/W7223232130","https://openalex.org/W4240050094","https://openalex.org/W4225257074","https://openalex.org/W7214701490","https://openalex.org/W2925533801"],"abstract_inverted_index":{"This":[0,76,87],"study":[1],"examines":[2],"the":[3,23,28,78,91,114,117,126,136,139,162],"regulatory":[4,120,132,176],"requirements":[5],"for":[6,65,69,80,138,168,179,184],"paediatric":[7,45,81,96,142],"oncology":[8],"drugs":[9],"in":[10,16,50,145],"Japan":[11],"and":[12,33,36,58,84,104,129,154,182],"India":[13],"are":[14,67],"compared":[15],"this":[17,107],"abstract.":[18],"It":[19],"draws":[20],"attention":[21],"to":[22,99,157,165],"frameworks":[24,121],"set":[25],"up":[26],"by":[27],"Ministry":[29],"of":[30,94,119,141],"Health,":[31],"Labour":[32],"Welfare":[34],"(MHLW)":[35],"India's":[37],"Central":[38],"Drugs":[39],"Standard":[40],"Control":[41],"Organization":[42],"(CDSCO).":[43],"The":[44],"population":[46],"differs":[47],"from":[48],"adults":[49],"several":[51],"ways,":[52],"including":[53,125],"physiological":[54],"factors,":[55],"pharmacokinetics,":[56],"pharmacodynamics,":[57],"dosage":[59],"administration.":[60],"However,":[61],"many":[62],"medications":[63],"prescribed":[64],"children":[66,169],"formulated":[68],"adults,":[70],"necessitating":[71],"dose":[72],"adjustments":[73],"throughout":[74],"childhood.":[75],"underscores":[77],"need":[79],"drug":[82,97,143],"formulations":[83],"regulations":[85,98,144],"worldwide.":[86],"research":[88],"delves":[89],"into":[90],"intricate":[92],"landscape":[93],"international":[95,131],"elucidate":[100],"key":[101],"initiatives,":[102],"challenges,":[103],"advancements":[105],"shaping":[106],"field.":[108],"Commencing":[109],"with":[110,170],"a":[111],"historical":[112],"backdrop,":[113],"review":[115],"outlines":[116],"evolution":[118],"across":[122],"major":[123],"regions,":[124],"Japan,":[127],"Europe,":[128],"other":[130],"frameworks,":[133,177],"while":[134],"underscoring":[135],"imperative":[137],"implementation":[140],"India.":[146],"Regulations":[147],"mandate":[148],"age-appropriate":[149],"dosing,":[150],"rigorous":[151],"clinical":[152],"trials,":[153],"thorough":[155],"labelling":[156],"prevent":[158],"misuse.":[159],"While":[160],"both":[161],"nations":[163],"strive":[164],"enhance":[166],"outcomes":[167],"cancer,":[171],"their":[172],"approaches,":[173],"particularly":[174],"concerning":[175],"incentives":[178],"pharmaceutical":[180],"innovation":[181],"mechanisms":[183],"ensuring":[185],"patient":[186],"access,":[187],"exhibit":[188],"significant":[189],"differences.":[190]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-31T00:00:00"}